Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) Major Shareholder Sells $26,168.33 in Stock
MarketBeat
Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) major shareholder Bioventures 2018 L.P. Mpm sold 3,733 shares of Entrada Therapeutics stock in a transaction dated Friday, August 28th. The stock was sold at an average price of $7.01, for a total value of $26,168.33. Following the completion of the transaction, the insider directly owned 4,275,693 shares of the company's stock, valued at approximately $29,972,607.93. This represents a 0.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Large shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.
NASDAQ:TRDA
